Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    -10.00 (-0.43%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

15 Sep 2023 07:00

RNS Number : 5208M
RIT Capital Partners PLC
15 September 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

 

15 September 2023

 

31 August 2023 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 August 2023 (with debt at fair value) was 2,399p per £1 ordinary share (31 July 2023: 2,402p).

 

 

August 2023 Highlights

 

A faster acceleration in global bond yields caused a meaningful downdraft in global equity markets. In the US, for example, Fitch Ratings' downgrade of the United States' credit rating, the Treasury's higher than expected borrowing intentions and robust economic data led to higher government yields. This in turn pushed down equity markets, with the MSCI ACWI (50% £) declining nearly -2% during the month. Renewed concerns over the Chinese economy, especially around the weak property sector and lack of stimulus, drove Chinese stocks lower (CSI 300 -6%). Against that backdrop, our portfolio finished approximately flat for the month, as our low quoted equity exposure, hedging and currency positioning shielded us from the large market declines.

 

· Our Quoted Equities book detracted during the month, with the decrease driven mainly by Chinese holdings, partly offset by positive contributions from Japanese holdings and gains in share prices of quality businesses such as Tempur Sealy and Mastercard.

· Private Investments also detracted slightly, driven by updated marks from our private fund positions. As of 31 August, approximately 80% of our private funds had reported valuations to 30 June and approximately 20% were held at 31 March valuations.

· Our Uncorrelated Strategies book contributed positively during the month, driven by healthy contributions from our positions in carbon credits and market neutral strategies.

· The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of August, the Company repurchased approximately 0.9 million shares on behalf of shareholders.

· The Company continues to maintain a strong liquidity position.

 

 

For more information:

J. Rothschild Capital Management (Investment Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFFXKLFBBZ
Date   Source Headline
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20251:00 pmRNSDirector/PDMR Shareholding
24th Dec 20251:00 pmRNSDirector/PDMR Shareholding
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSNet Asset Value(s)
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:21 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 202512:41 pmRNS-RUpdate from QuotedData
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSNet Asset Value(s)
14th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20254:56 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.